Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bleeding disorders in neonates.
Kenet G, Chan AK, Soucie JM, Kulkarni R. Kenet G, et al. Among authors: chan ak. Haemophilia. 2010 Jul;16 Suppl 5:168-75. doi: 10.1111/j.1365-2516.2010.02316.x. Haemophilia. 2010. PMID: 20590877 Review.
HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The 'HERBAL' Trial.
Chan A, Chan D, Ng DQ, Zheng HF, Tan QM, Tan CJ, Toh JHM, Yap NY, Toh YL, Ke Y, Wang ECA, Lim QPN, Ho HK, Chew L, Tan TJ. Chan A, et al. Integr Cancer Ther. 2025 Jan-Dec;24:15347354251314514. doi: 10.1177/15347354251314514. Integr Cancer Ther. 2025. PMID: 39840742 Free article. Clinical Trial.
Novel Neurocognitive Testing Tool for Early Neurotoxicity Detection Following Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-cell Therapy: A Pilot Study.
Suresh A, Wishart HA, Arslan MN, Lizcano RA, Shah PS, PonnamReddy S, Hayes CA, Jacobson BS, Moncrief G, Martinez-Camblor P, Chan AM, Meehan KR, Hill JM Jr. Suresh A, et al. Among authors: chan am. Clin Lymphoma Myeloma Leuk. 2024 Dec 24:S2152-2650(24)02448-0. doi: 10.1016/j.clml.2024.12.011. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39814673 Free article.
The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN-GIL hybrid single-molecule inhibitors.
Goodis CC, Eberly C, Chan AM, Kim M, Lowe BD, Civin CI, Fletcher S. Goodis CC, et al. Among authors: chan am. Eur J Med Chem. 2024 Dec 22;285:117190. doi: 10.1016/j.ejmech.2024.117190. Online ahead of print. Eur J Med Chem. 2024. PMID: 39813774
9,463 results